The abstract is read at the publisher; the summary is JClub's.
Human iPSC-derived cardiac models spanning 2D to heart-on-chip systems capture key features of myocardial infarction and are increasingly used for therapeutic discovery and regenerative repair.
- Why it matters: MI remains a leading cause of death, yet therapies that limit injury, promote repair, and restore cardiac function are still limited. The field needs better human-relevant models to study MI stages and support translation.
- What they did: The review surveys hiPSC-based cardiac systems—from 2D cultures to 3D tissues, organoids, and heart-on-chip—assessing how well they reproduce human MI pathophysiology. It also covers their use in drug screening, precision medicine, and regenerative strategies.
- The result: These models are linked to studying multiple MI stages and to therapeutic discovery and regenerative approaches, while the authors prioritize improved physiological complexity, translational robustness, bioengineering, and multi-omics integration.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.